Xiyun Chai - Concepedia

Concepedia

Author

Xiyun Chai

Eli Lilly (United States)

Also Known As

X. Chai, Xiyun Chai

24

Publications

5.8K

Citations

11

H-Index

28

Concepts

All Affiliations

Eli Lilly (United States)Skåne University Hospital Lund University University College London University of Gothenburg

XC

About

Xiyun Chai is an author at Eli Lilly (United States) specializing in medicine, neurodegenerative diseases, and neurodegeneration.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	2.3K
2	Natural Sciences	1	1	234
3	Social Sciences	1	1	36
4	Biochemistry	1	1	234
5	Cell Biology	1	1	346

Xiyun Chai

×

12

Publications

5.8K

Citations

11

H-Index

	Year	Citations
Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders Sebastian Palmqvist, Shorena Janelidze, Yakeel T. Quiroz, JAMA	2020	1.4K
Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia Shorena Janelidze, Niklas Mattsson, Sebastian Palmqvist, Nature Medicine Neurodegenerative DiseasesPlasma P-tau181Alzheimer's DiseaseAgingLongitudinal Progression	2020	1.2K
Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration Elisabeth H. Thijssen, Renaud La Joie, Amy Wolf, Nature Medicine Frontotemporal Lobar DegenerationNeurodegenerative DiseasesAlzheimer's DiseaseAgingDiagnostic Value	2020	767
Plasma phospho‐tau181 increases with Alzheimer's disease clinical severity and is associated with tau‐ and amyloid‐positron emission tomography Michelle M. Mielke, Clinton E. Hagen, Jing Xu, Alzheimer s & Dementia	2018	643
Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease Shorena Janelidze, Erik Stomrud, Ruben Smith, Nature Communications	2020	437
Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer’s disease Niklas Mattsson, Emelie Andersson, Shorena Janelidze, Science Advances	2020	347
Passive Immunization with Anti-Tau Antibodies in Two Transgenic Models Xiyun Chai, Su Wu, Tracey K. Murray, Journal of Biological Chemistry Transgenic Mouse ModelsPassive ImmunizationImmunologyAntigen ProcessingImmunotherapy	2011	346
Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease Sebastian Palmqvist, Philip S. Insel, Erik Stomrud, EMBO Molecular Medicine	2019	346
Constitutive secretion of tau protein by an unconventional mechanism Xiyun Chai, Jeffrey L. Dage, Martin Citron Neurobiology of Disease Protein SecretionProtein FunctionBiochemistryNatural SciencesMolecular Biology	2012	234
Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease Shorena Janelidze, Erik Stomrud, Ruben Smith, Geriatric PsychiatryCsf P-tau217AgingNeurochemical BiomarkersAbnormal Tau Metabolism	2020	36

Page 1